Objective: This study was designed to examine the psychometric properties and measurement equivalence of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Cognitive Function (Version 3) (FACT-Cog) in multiethnic Asian patients with breast cancer. Methods: This prospective study involved patients with breast cancer from the National Cancer Centre Singapore. The concurrent validity of the FACT-Cog was assessed according to its strength of correlation with the validated European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 cognitive functioning scale, and its association with fatigue, global health status, and anxiety. The known-group validity was assessed on the basis of receipt of chemotherapy. Factor analysis was conducted to ascertain the one-factor structure of each cognitive domain. The reliability was evaluated by using Cronbach's alpha and intraclass correlation coefficient within the cognitive domains. Multiple regression analyses were performed to compare the total scores between the two language versions, adjusting for covariates. Results: A total of 185 English-speaking and 143 Chinese-speaking patients were recruited. Both the English and Chinese FACT-Cog total scores correlated strongly with the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 cognitive functioning scale scores (r ¼ 0.725 and 0.646), whereas correlations with fatigue, anxiety, and global health status were weak to moderate (|r| ¼ 0.376-0.589). Regarding the known-group validity, more severe perceived cognitive disturbance was observed among patients receiving chemotherapy than among those who were not for both versions (P ¼ .010 and .008, respectively). Internal consistencies within the cognitive domains were high (Cronbach's α 0.707-0.929), and test-retest reliability was satisfactory for both versions (intraclass correlation coefficient 0.762 and 0.697). The measurement equivalence between the English and Chinese versions was established for all domains except the multitasking domain. Conclusion: The English and Chinese versions of the FACT-Cog are valid, reliable, and equivalent for clinical and research use.
Introduction
A substantial amount of research has suggested that cognitive impairment affects 19% to 78% of the patients with breast cancer [1] [2] [3] [4] . In the literature, the terms "chemobrain" and "chemofog" have been used to refer to the subtle yet notable deterioration in patients' cognitive domains, which include memory, concentration, mental acuity, learning, processing speed, and executive functioning. To emphasize, this worsening of cognitive function may be subtle, but studies have shown that it can have a detrimental effect on the health-related quality of life (HRQOL) and functional independence of patients with breast cancer [5] [6] [7] .
The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), currently in its third version, is a questionnaire that evaluates patients' self-reported perceptions of their cognitive abilities and the effects of these cognitive changes on their HRQOL [8, 9] . The FACT-Cog distinguishes itself from other available subjective neuropsychological tests because the questionnaire focuses on the noticeability and functional interference of the multiple specific domains associated with perceived cognitive functioning. The FACT-Cog has been used in several studies to assess the presence of subjective cognitive deficits in patients with cancer [1, [10] [11] [12] [13] . There is currently limited data on psychometric properties of the FACT-Cog. An older version of the FACT-Cog (version 2) was validated within the hematopoetic stem cell transplant population [13] . The FACT-Cog (version 3) is available in French, and it has yielded good linguistic validation results within French patients with cancer [14] . The current English and Chinese versions of the FACT-Cog, however, have not been validated for use in research and clinical settings within the Asian population with breast cancer. Specific research on the reliability and other measurement properties of the Chinese version of the FACT-Cog has also not been published in the literature.
Because there is evidence in the literature to show that ethnicity, language, and cultural preferences can influence patients' perception of cognitive functioning [5, 15] , the validation of the English and Chinese versions of the FACT-Cog within Asian patients with breast cancer is essential to determine whether its results can be used with confidence as a reliable instrument in future epidemiological studies and clinical trials. Establishing the equivalence between the English and Chinese versions of the FACT-Cog will also allow the results from both languages to be pooled for future research. Hence, we designed this study to evaluate the validity of the English and Chinese versions of the FACT-Cog in the context of a multiethnic Asian population with breast cancer, and to determine the measurement equivalence between these two versions.
Methods

Study and Setting
This prospective study was conducted at the outpatient clinics of the National Cancer Centre Singapore from November 2010 to August 2012. The National Cancer Centre Singapore is the largest ambulatory cancer center in Singapore and treats 70% of the annual cancer population. This study was approved by the Singhealth Institutional Review Board.
Patients
The patients who were recruited to participate in this study were histologically diagnosed with breast cancer by a medical oncologist, were at least 18 years old, were ambulatory in nature (defined as having an Eastern Cooperative Oncology Group performance status score of 0 or 1), spoke English or Chinese as their mother tongue, and were willing to give informed consent. Patients were excluded from the study if breast cancer was a secondary malignancy, or patients presented with evidence of brain metastasis, psychosis, or any underlying neuropsychiatric illness that might impair their cognitive abilities. Patients' medical histories and medication records (extracted from a comprehensive in-house database) were reviewed to ensure that they had not been prescribed neuropsychiatric or psychotropic medications. Patients were classified into English-speaking and Chinese-speaking on the basis of their indicated mother tongue or preferred choice of language for routine reading (e.g., newspapers and books), writing, and communication. Eligible patients were recruited from the outpatient clinics to ensure a heterogeneous and representative sample of patients (in terms of treatment status and time since diagnosis of cancer) for this validation study.
Study Procedures
The patients' demographic and medical information was obtained from the existing electronic databases available at the National Cancer Centre Singapore. Data on patients' cancer treatment, chemotherapy protocol, and the use of complementary alternative medicine such as traditional Chinese medicine and vitamins or other nutritional products were also collected. Three questionnaires-the FACT-Cog, the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC-QLQ-C30) cognitive functioning scale, and the Beck Anxiety Inventory (BAI)-were administered to patients by interviewers on recruitment. English and Chinese versions were available for all questionnaires, and these were administered to the English-speaking and Chinese-speaking groups, respectively. All interviewers were bilingual and underwent training to ensure consistency in questionnaire administration.
Tools
FACT-Cog
The FACT-Cog contains 37 items, with subscales created by the developers consisting of 1) patients' perceived cognitive impairments, 2) perceived cognitive abilities, 3) noticeability or comments from others, and 4) impact of cognitive changes on quality of life [16] . A global or summary score is obtained by summing all the item scores. Given that our focus here was to examine the psychometric properties and measurement equivalence of the FACT-Cog based on its cognitive domains, items in subscales 1) and 2) were regrouped into their cognitive domains before data analysis, according to the developer's original classifications and the expertise of a neuropsychologist in our research team [9, 17] . This approach was adopted so as to facilitate the mapping of patient-reported cognitive outcomes from the FACT-Cog with the individual cognitive domains of objective neuropsychological test performances in future studies [18, 19] . Hence, this study involved the validation of subscales 3) and 4) and the six reclassified cognitive domains of interest: mental acuity, attention and concentration, memory, verbal fluency, functional interference, and multitasking ability ( Table 1 ). The items are rated for the previous week, including the day of administration. Each item is rated on a five-point Likert scale, ranging from 0 ("Never" or "Not at all") to 4 ("Several times a day" or "Very much"). The total score for the FACT-Cog can range from 0 to 148 points, with a higher score indicative of better perceived cognitive functioning.
The English version of the FACT-Cog was translated into simplified Chinese by investigators proficient in both languages. The translation closely followed the guidelines stipulated by the Translation and Cultural Adaptation-Principles of Good Practice [20] . The questionnaire was forward-and backward translated, reconciled by independent parties, and underwent cognitive pretesting with a representative and culturally homogeneous sample of 30 bilingual Singaporean patients to identify items that were offensive and/or structurally difficult to understand within the local context [5, 20] . The final reconciled version was approved by the Functional Assessment of Chronic Illness Therapy.
The EORTC-QLQ-C30
The EORTC-QLQ-C30 (referred to as QLQ-C30 hereafter) is a questionnaire developed to assess cancer patients' HRQOL [21] . It contains 30 items that are grouped into five functional domains (physical, role, cognitive, emotional, and social), three symptom domains (fatigue, pain, and nausea/vomiting), a global quality-oflife domain, and six individual items (dyspnea, insomnia, anorexia, diarrhea, constipation, and financial stability). Items are rated for the previous week, including the present day. Each of the items, with the exception of the global quality-of-life domain, is rated on a four-point Likert scale, ranging from 1 ("Not at all") to 4 ("Very much"). The global quality-of-life domain is rated on a seven-point Likert scale, with 1 being "very poor" and 7 being "excellent." The score for each domain ranges from 0 to 100 points. Higher scores in the functional and global quality-of-life domains are indicative of better functioning or health status, while higher scores in the symptom domains and individual symptom items are indicative of worse symptoms. Both the English and Chinese versions of the QLQ-C30 have been validated within the cancer population in Singapore [22] . 
Of interest to this study is the cognitive functioning scale, which contains two items that investigate memory ("Have you had difficulty remembering things?") and attention deficits ("Have you had difficulty in concentrating on things, like reading a newspaper or watching television?") in the past week. This QLQ-C30 cognitive functioning scale is used as an anchor for the evaluation of test-retest reliability of the FACT-Cog.
BAI
The BAI is a validated questionnaire comprising 21 self-reported anxiety-associated symptoms, the severity level of which patients rate on a four-point Likert scale, ranging from 0 ("Not at all") to 3 ("Severe") [23] . The score for the BAI ranges from 0 to 63 points. A higher BAI score is indicative of a higher level of anxiety symptoms. Both the English and Chinese versions of the BAI have been used to evaluate the presentation of anxietyrelated symptoms in patients with breast cancer in Singapore [24] .
Data Analysis
All statistical analyses were conducted with SPSS Statistics Version 20. Missing values in the FACT-Cog, the QLQ-C30, and the BAI were managed as stipulated by the respective questionnaire manuals. Descriptive statistics were used to describe the demographic and clinical characteristics of the sample. A comparison was conducted regarding the baseline characteristics of the English-and Chinese-speaking groups by using independent t tests or Mann-Whitney U tests for continuous measures and chisquare or Fisher exact tests for differences in categorical measures. All the two-tailed significance tests were conducted by using a P value significance level of less than .05.
Validity
Assessing the validity of the FACT-Cog entailed that it measures a patient's self-reported cognitive complaints or perceived cognitive functioning. A correlation analysis was performed between the QLQ-C30 cognitive functioning scale and the total FACT-Cog scores. The QLQ-C30 cognitive functioning scale was used because it has been previously validated in multiple international studies and in Singapore [21, 22, 25, 26] . We hypothesized that the FACT-Cog scores would correlate positively with the QLQ-C30 cognitive functioning scale.
A convergent validity analysis was performed to determine whether the FACT-Cog total score correlated with its known related constructs. Studies have shown that fatigue, anxiety, and a poorer global health status have a negative effect on cancer patients' cognitive abilities [1] [2] [3] [4] [5] [6] . By using the QLQ-C30 fatigue scale and global health status rating, we hypothesized that a lower FACT-Cog score would correlate with patients exhibiting a higher level of fatigue and a decreased global health status rating. By using the total score from the BAI, we hypothesized that a lower FACT-Cog score would correlate with patients exhibiting higher BAI scores or more severe anxiety.
In all the above correlation tests for concurrent and convergent validities, an absolute correlation coefficient value of 0.7 and above was indicative of a strong correlation, an absolute correlation coefficient value of 0.4 to 0.7 indicated a moderate correlation, and an absolute correlation coefficient value between 0 and 0.4 indicated a weak correlation [27] .
Known-group validity was performed to determine the significance of the differences between the FACT-Cog scores of the groups known to have varying degrees of perceived cognitive impairment. Because FACT-Cog items were first developed by soliciting patient descriptions of cognitive problems postchemotherapy [1-9], we hypothesized that patients who had completed chemotherapy at the point of survey administration would report poorer cognitive functioning, reflected by lower FACT-Cog scores, than would those who were not exposed to chemotherapy (also termed as "chemotherapy-naive" patients).
A principal-component factor analysis was conducted to ascertain the one-factor structure of each cognitive domain. Unidimensionality would be confirmed if only one component of each cognitive domain had an eigenvalue of more than 1.0 (Kaiser-Guttman criterion) [28] [29] [30] [31] .
Reliability
The internal consistency reliability between the individual items of the same cognitive domain was evaluated by using Cronbach's alpha [32] . A Cronbach's alpha of 0.7 and above represented satisfactory consistency. To identify problematic or irrelevant items that were not consistent with the other items in the domain, an item-to-domain correlation analysis was also performed. The corrected item-to-scale correlation was calculated for each item by removing the contribution of the item to the domain score. Any items with a correlated item-to-scale correlation of less than 0.5 were identified.
Approximately 4 to 6 weeks after baseline assessment, a random sample of patients recruited between May and October 2012 was invited to complete the FACT-Cog and respond to two anchor questions that were obtained from the QLQ-C30 cognitive functioning domain in the same language again through interview during their scheduled follow-up consultation at the clinic. The test-retest reliability was investigated by determining the intraclass correlation coefficient (ICC) of the scores for the patients who completed the follow-up assessment within 45 days and stated "no change" to the two anchor questions [33, 34] . This time frame was chosen because oncology practitioners in our cancer institution typically arrange for follow-up consultations with patients at least once every 45 days, and on the basis of clinical observation that ambulatory patients with breast cancer commonly do not experience significant changes in their HRQOL and cognitive functioning within a span of 45 days. For individual patient assessment, an ICC of 0.7 or higher is considered as "satisfactory." The mean difference between the baseline and follow-up total FACT-Cog scores and cognitive domain scores were evaluated. Currently, minimal clinically important difference (MCID) is not determined for the FACT-Cog; hence, we defined the MCID as 4% to 6% of the total score on the basis of established guidelines [35, 36] . Because the literature has shown that cognitive changes experienced by patients with cancer are subtle in nature [2, 5] , we selected the stricter and more conservative lower limit of 4% as the MCID. Therefore, if the mean differences of the baseline and follow-up scores were within 4% of the total FACT-Cog or cognitive domain score, test-retest reliability would be considered as "satisfactory."
Measurement equivalence
The equivalence of English and Chinese FACT-Cog was evaluated by examining whether score differences between these versions were clinically important. By using the methodology for assessing therapeutic equivalence in clinical trials, the 95% CIs of FACT-Cog total and cognitive domain score differences were compared with predefined equivalence margins to determine whether differences in scores were clinically important or unimportant [37, 38] . A multiple regression analysis was performed to estimate the comparability of the mean scores obtained from both versions after adjusting for demographic and health differences and known related constructs that might prompt a change in patients' cognitive functioning. It was important to adjust for the influence of these variables when assessing the influence of language because observed differences in FACT-Cog scores might be caused by these determinants rather than by questionnaire language. Clinically relevant factors that were decided a priori for adjustment included age [39] , years of education [40] , receipt of complementary alternative medicine (gingko [41] , traditional Chinese medicines, vitamins and nutritional products [42] [43] [44] [45] [46] ), menopausal status [47, 48] , hemoglobin levels [49] , receipt of chemotherapy, anxiety (depicted by BAI scores) [6] , fatigue (depicted by QLQ-C30 fatigue scale scores) [50] [51] [52] , HRQOL (depicted by QLQ-C30 global health status scale) [53] , cancer stage [54] , and receipt of endocrine therapy [40, [55] [56] [57] . To adjust for the other exploratory variables in the model, these variables must be statistically significant at a cutoff P value of .05 in the univariate analysis, considered clinically relevant and postulated to contribute to the clinical presentation of cognitive impairment in patients with breast cancer, based on the consensus among the clinicians in the research team. This approach was adopted to prevent detraction from the statistical power by including clinically irrelevant variables in the model. Equivalence was established if the 95% CI of the adjusted mean difference fell within the equivalence margin of Ϯ0.25 SD. Should the 95% CI fall out of Ϯ0.25 SD, the equivalence is still acceptable if it does not exceed Ϯ0.5 SD, which is the threshold or upper limit for a small detectable change [37] .
Results
Patient Characteristics
A total of 328 patients participated in the study, of which 185 (56.4%) were English-speaking and 143 (43.6%) were Chinesespeaking ( Table 2 ). The mean age of all the patients was 51.8 Ϯ 9.7 years. The majority of the patients were Chinese (86.2%) with early-stage breast cancer. Statistically significant differences were not observed among the demographic and clinical characteristics such as marital status, hemoglobin level, presence of comorbidities, cancer staging, Eastern Cooperative Oncology Group, receipt of endocrine therapy, chemotherapy, and complementary alternative medicine. The Chinese-speaking patients, however, were older than their English-speaking counterparts (55.1 Ϯ 8.3 years vs. 49.3 Ϯ 10.0 years, P o .001). Compared with the English-speaking patients, the Chinese-speaking patients generally had fewer years of education (11.8 Ϯ 1.0 vs. 7.4 Ϯ 2.5, P o .001), were unemployed (44.9% vs. 60.8%, P ¼ 0.005), and were largely postmenopausal (51.9% vs. 63.6%, P ¼ .034). These demographic and health differences could be attributed to the disparity in ages between the English-and Chinese-speaking patients.
Questionnaire Scoring
FACT-Cog
The mean scores for FACT-Cog total and domains scores are summarized in 
QLQ-C30
The mean cognitive functioning scores from the QLQ-C30 showed no statistical differences between the English-and Chinese-speaking (Table 4 ). Statistically different scores, however, were observed between the English-and Chinese-speaking patients in the following HRQOL domains of the QLQ-C30: physical functioning (P ¼ .003), role functioning (P ¼ .0001), emotional functioning (P ¼ .002), social functioning (P ¼ .004), fatigue (P o .0001), and pain (P ¼ .036).
BAI
The BAI detected more anxiety symptoms among Englishspeaking patients than among their Chinese-speaking counterparts (9.1 Ϯ 9.1 vs. 7.3 Ϯ 5.9, P ¼ .038) ( Table 4 ).
Validity Assessment
Concurrent validity
A moderate-to-strong correlation between the FACT-Cog total score and the QLQ-C30 cognitive functioning scale score was observed for both the English and Chinese versions (r ¼ 0.725 and 0.646, respectively).
Convergent validity
The QLQ-C30 fatigue scale and the FACT-Cog total scores were moderately-to-poorly correlated for the English and Chinese versions (r ¼ À0.376 and À0.448, respectively). The correlations between anxiety scores (the BAI total score) and the FACT-Cog total scores for the English and Chinese versions were moderate (r ¼ À0.589 and À0.567, respectively). The correlations between the QLQ-C30 global health status score and the FACT-Cog total score were moderate among the English-speaking patients (r ¼ 0.580) and Chinese-speaking patients (r ¼ 0.511). For both language versions, the correlations between individual cognitive domains and the known-related constructs of fatigue, global health status, and anxiety were weak to moderate (|r| ¼ 0.345-0.577, all P o .05).
Known-group validity
Both versions of the FACT-Cog were able to discriminate between patients who had completed chemotherapy and those who were not exposed to chemotherapy. Both English-speaking and Chinese-speaking patients who received chemotherapy reported more cognitive disturbances than did patients who had no prior exposure to chemotherapy (English-speaking: 123.1 Ϯ 23.8 vs. 130.9 Ϯ 17.0, P ¼ .010; Chinese-speaking: 122.0 Ϯ 17.9 vs. 131.0 Ϯ 17.0, P ¼ .008).
With regard to the individual cognitive domains, patients receiving chemotherapy reported consistently lower scores than did those who were not exposed to chemotherapy (all P o .01). Known-group validity between chemotherapy-receiving and non-chemotherapy-receiving patients, however, was not achieved for the subdomain of "noticeability" for both Englishand Chinese speaking patients (English-speaking: 14 
Factor analysis
For both language versions, unidimensionality was derived from factor analysis for the domains of "concentration," "verbal ability," "functional interference," "multitasking," "noticeability," and "impact on quality of life," suggesting that the individual items within these domains could be summed to generate a single domain score. The cumulative single items for the above domains accounted for 67.3% to 74.2% of the total variance for both languages, and the loadings of the items on each single domain were similar and high.
Unidimensionality, however, was not confirmed for the memory and mental acuity domains. It was noted that two items (CogM9 and CogA1) were poorly loaded to their respective domains of memory and mental acuity. 
Reliability Assessment
Internal consistency and item-to-scale correlation The Cronbach's alpha for the English-and Chinese-speaking patients' FACT-Cog cognitive domain scores ranged from 0.707 to 0.929 ( Table 1 ). The Cronbach's alpha for the Chinese version was generally observed to be lower than that for the English version for all domains. There were, however, satisfactory internal consistencies within each of the domains for both languages.
The item-to-domain analyses identified four items that had poor correlations (r o 0.500) with the other items in the same domain: CogM9 and CogM12 from the memory domain, CogA1 from the mental acuity domain, and CogO1 from the noticeability subscale.
Test-retest reliability
A total of 152 patients were approached for the follow-up assessment, of which 145 patients (95.4%) completed the FACT-Cog questionnaire for the test-retest reliability analysis. Of these 145 patients, 70 (48.3%) patients indicated "no change" to the anchor questions from the QLQ-C30 cognitive functioning scale and their results were considered valid for analysis. Thirty-nine (55.7%) were English-speaking patients, and 31 (44.3%) were Chinesespeaking patients. The mean duration from baseline to follow-up assessment was 40.9 Ϯ 21.2 days. The ICC values for the FACT-Cog total score were satisfactory for both English and Chinese versions (ICC 0.762 and 0.697, respectively). The mean difference between the baseline and follow-up total FACT-Cog scores was À1.01 points (95% CI À3.98 to 1.95), which was much lower than the predefined MCID of 5.9 points (4% of the total FACT-Cog score).
The test-retest reliabilities for the individual cognitive domains were fairly satisfactory, as indicated by ICC values ranging from 0.673 to 0.793. All the ICC values for the individual cognitive domains were above 0.7, with the exception of the Chinese "mental acuity" domain (ICC 0.673). For all cognitive domains, the mean differences between the baseline and followup cognitive domain scores ranged from 1.2% to 3.8%, and all fell within the predefined minimal clinically important threshold of 4.0% of the total domain scores.
Measurement Equivalence of the English and Chinese Versions
All clinically relevant variables that were decided a priori under the methodological section and all statistically significant variables in Tables 2 and 4 were adjusted in the regression model for evaluating measurement equivalence between English and Chinese versions (Table 3) , with the exception of the variables "nausea and vomiting" and "dyspnea" because it is irrelevant or illogical to demonstrate that they contribute to the subtle cognitive impairment in patients with cancer. The final regression model showed that significant difference was not observed FACT-Cog, Functional Assessment of Cancer Therapy-Cognitive Function. Ã Mean difference adjusted to clinically relevant variables that were decided a priori: age in years, education in years, receipt of complementary alternative medicines, menopausal status, hemoglobin level, receipt of chemotherapy, anxiety, fatigue, global health status, stage and receipt of endocrine therapy, and variables that showed statistical differences between the English-and Chinese-speaking groups in Tables 2 and 4 : race (Chinese vs. non-Chinese), work status (employed vs. unemployed), presence of comorbidities, physical functioning, role functioning, emotional functioning, and social functioning. † Denotes that the 95% CI exceeded both the Ϯ0.25 SD equivalence margin and the Ϯ0.5 SD equivalence margin threshold. between the two groups in the FACT-Cog total scores and the cognitive domains of memory, verbal ability, concentration, mental acuity, and functional interference or in the subscales of noticeability and influence on quality of life. Ninety-five percent of the CIs for the adjusted difference between the scores of both languages fell within the Ϯ0.5 SD margin. The 95% CI of the difference in scores between the English and Chinese versions in the multitasking domain, however, fell outside the Ϯ0.25 SD equivalence margin and exceeded the Ϯ0.5 SD threshold or upper limit for a small detectable change. This suggests that the equivalence between the English and Chinese versions was questionable in the multitasking domain.
Discussion
This is the first study to evaluate the validity, reliability, and equivalence of the English and Chinese versions of the FACT-Cog. Our results reveal that both versions of the FACT-Cog are equivalent, valid, and reliable to a great extent in assessing the perceived cognitive functioning of Asian patients with breast cancer. An adaptation of the FACT-Cog in the sociocultural context of Asian population and the evaluation of its psychometric properties is essential to the accurate interpretation of results in clinical studies [5] .
The results obtained from the concurrent validity analysis demonstrated that the English and Chinese FACT-Cog total scores had strong and moderate correlations, respectively, with the validated QLQ-C30 cognitive functioning scale. The convergent validity analysis revealed that the correlations between the FACT-Cog total scores and patients' anxiety, fatigue, and global quality-of-life level were weak to moderate. Similar results were observed in the validation of the English FACT-Cog (version 2) in 101 patients with cancer who underwent hematopoetic stem cell transplantation; the correlation between FACT-Cog total scores and the constructs of depression, anxiety, and fatigue were weak to moderate (IrI ¼ 0.36-0.60) [13] . A strong correlation was not obtained, likely because of the multifactorial nature of cognitive impairment, which consists of various clinical, pharmacological, and psychosocial confounders such as depression, receipt of neurodegenerative drugs, distress, mood changes, and the patients' genetic predispositions [58] [59] [60] . Furthermore, it has been proposed that interacting effects might exist among psychological, psychosocial, and demographic factors in the "chemobrain" phenomenon [1, 61] . Therefore, no single attribute is sufficient to create a strong correlation with greater perceived cognitive impairment. In the validation study, the choice of fatigue, anxiety, and HRQOL as the constructs of interest was valid because these variables have been substantially described in the literature as associated with perceived cognitive functioning [6, [50] [51] [52] [53] .
Results from known-group validity analysis suggested that both versions of the FACT-Cog were able to discriminate patients on the basis of their chemotherapy treatment status. Choice of known-groups in the assessment of perceived cognitive functioning poses a challenge for this validation study. Receipt of (Table 3) , with the exception of the variables "nausea and vomiting" and "dyspnea" because it is irrelevant or illogical to demonstrate that they contribute to the subtle cognitive impairment in patients with cancer. † A higher score is indicative of a better functioning/health status. The theoretical range for the global and functional scales is 0 to 100. ‡ A higher score is indicative of more symptoms/difficulties. The theoretical range for the symptom scales and single items is 0 to 100. § A higher score is indicative of more symptoms/difficulties. The theoretical range for the BAI is 0 to 63. chemotherapy was selected as the basis for comparison instead of other potential choices, such as presence of brain metastases [62, 63] , receipt of brain radiation therapy [64] , and other severe neuropsychiatric disorders such as dementia or Alzheimer's disease [65, 66] . These conditions can potentially lead to cognitive decline in patients. Because this study aims to validate the capability of the FACT-Cog to detect subtle cognitive changes in patients with cancer, neuropsychological conditions that drastically affect brain functioning may generate extreme results and are not suitable for this purpose. To complement our results, it is recommended that future work should consider administering the FACT-Cog to healthy individuals in order to get normative values for the general population [14] .
We also scrutinized the validity, reliability, and measurement equivalence of a subjective neuropsychological assessment on the basis of its cognitive domains, instead of its originally proposed subscales or a global scale. It is noted that selfreporting tools most commonly use a global or summary scale rather than the specific domains of cognitive complaints. Although earlier studies have shown that the results of objective and subjective neuropsychological assessments do not correlate, some research has suggested otherwise when results are compared according to specific domains rather than overall scores [18, 19, 67, 68] . In future research, the criterion validity of the FACT-Cog could be conducted by examining the relationship between the specific domains of subjective cognitive complaints and objective neuropsychological batteries.
Both versions of the FACT-Cog have demonstrated satisfactory internal consistencies among the cognitive domains and test-retest reliability. Factor analyses and item-to-domain correlations have also revealed that the majority of the items in the FACT-Cog relate well to the constructs of their respective cognitive domains. CogM9 and CogM12, however, were highlighted as problematic items within the memory domain. Because these results were observed in both the English and Chinese versions, the poor item-to-domain correlations could be due to problems with the original item, rather than translation errors. For CogM12, we postulate that using patients' ability to remember "phone numbers" and "simple instructions" to assess memory may not be relevant in today's context. Most patients need not remember such information, given the prevalence of technologies (e.g., mobile phones) that provide easy information storage and recall. We also observed that within the memory domain, CogM9 was identified as a problematic item that deviated from its underlying construct of memory. This could be due to the ambiguous nature of the content outlined by the item. The patients' inability to find their way to a "familiar place" might be indicative of a severe or clinically significant cognitive impairment, instead of the mild or subtle cognitive changes often observed in patients with cancer. Furthermore, many patients may have difficulty understanding the term familiar place because it is poorly defined and not tied to concrete examples.
Poor item-to-domain correlations were also observed with CogO1 and CogO4 for both language versions. A similar validation study of the French version of the FACT-Cog also identified CogO1 as having a poor item-to-total correlation within the subscale of "noticeability" (r ¼ 0.32) [14] . Moreover, the Chinese version of the noticeability domain could not differentiate patients who had completed chemotherapy from those who were not exposed to chemotherapy. This could be due to the sensitive nature of these items, which seek to obtain a third party's opinion of the patient's cognitive ability. When applied in the context of an Asian population that values communal living and kindred spirits, these comments are expected to be poorly received. The Asian patients with breast cancer who participated in one focus group study expressed that their family members provided them with good psychosocial support during their chemotherapy treatment, and were generally "forgiving and patient towards them" when they displayed cognitive lapses [5] . Thus, the responses to CogO1 and CogO4 may not be accurately reflected.
It was observed that the test-retest reliability is only fairly satisfactory (ICC 0.673) for the mental acuity domain. CogA1 was also identified by the factor analysis as relating poorly to the constructs of the mental acuity cognitive domains, especially within the Chinese version of the FACT-Cog. Poor item-todomain correlation observed with the Chinese FACT-Cog, which was not observed with the English FACT-Cog, suggests that cultural differences might have led to differential interpretations of the same item [5] . Despite repeated attempts to rephrase and refine this item during the pretesting stage, the phrase "trouble forming thoughts" is potentially open to misinterpretation and difficult to understand by patients. This was also observed with the validation of the French FACT-Cog, which required modifications to the translation of "forming thoughts" in the pretesting phase [14] . To improve comprehensibility and to ensure equivalence with the English source, we propose that retranslation and validation of CogA1 is needed. Caution must be taken in the interpretation of the mental acuity domain, particularly the Chinese version.
We also evaluated the measurement equivalence between the English and Chinese versions of the FACT-Cog. Although most cross-cultural patient-reported outcome study groups had undergone a vigorous translation process to ensure the content and semantic equivalence of the translated tool, it is imperative to evaluate the comparability and equivalence between the English and non-English versions of the FACT-Cog, because there is no assurance that the translated tool is equivalent to the original English version unless the comparability in the psychometric properties of the two tools is performed [69] . Measurement equivalence is necessary to facilitate the pooling of results from multinational clinical trials and identify problematic items that differ, in semantic structure, from the original language version [70] . Our FACT-Cog scores were adjusted on the basis of both clinically relevant and statistically significant demographic and health differences between both groups to evaluate the measurement equivalence of both versions. With the understanding that cognitive impairment in patients with breast cancer is a multifactorial phenomenon, we considered that adjusting for known related constructs could enhance the accuracy of the equivalence measure. Our analysis demonstrated that both versions are equivalent for the total score and all the cognitive domains, with the exception of the multitasking domain. Poor equivalence could be due to translation errors or differences in the cultural understanding of the items. The items in the multitasking ability domain involved asking patients about their ability to effectively perform tasks that require simultaneous thought. Hence, the difficulty and choice of tasks could be influenced by patients' lifestyles and cultural preferences. Caution must be taken when pooling the results of both language versions for this domain. Retranslation and refinement of the items are needed to improve their equivalence with the English source.
This study has a few limitations. In the concurrent validity analysis, the QLQ-C30 cognitive functioning scale consisted of only two items to evaluate patients' perceived concentration and memory. This could be seen as a methodological limitation because the QLQ-C30 is not the perfect standard for evaluating the concurrent validity of the FACT-Cog. The FACT-Cog's cognitive domains and items include additional domains that are not examined in the QLQ-C30. Our choice of the QLQ-C30 in this validation exercise, however, is well justified because there are no other validated questionnaires currently available that assess all the domains of perceived cognitive impairment in local patients with cancer. Finally, there was a lack of published validation studies on the FACT-Cog for cross-referencing our results. This is the first study to analyze the items in the FACT-Cog on the basis of their corresponding domains and total scores.
Future studies should evaluate the longitudinal validity and responsiveness of the FACT-Cog to cognitive changes within patients with breast cancer across separate time points. To facilitate the interpretation of the clinical relevance of score changes, identification of MCID can guide the clinical interpretation of patient-reported cognitive changes by providing recognizable end points. Finally, validation studies can be performed on other cancer populations to support the use of the FACT-Cog in oncology clinical and research settings.
Conclusions
The FACT-Cog is a valid and reliable instrument for assessing perceived cognitive functioning in Asian patients with breast cancer. A few items within the "memory," "mental acuity," and "noticeability" domains, however, feature content or examples that are culturally irrelevant or inappropriate and one should be cautious in interpreting results of these problematic items. The English and Chinese versions of the FACT-Cog have also demonstrated measurement equivalence. In addition, caution must be taken when the results of both versions are pooled for items within the multitasking domain. These items should undergo cross-cultural adaptation and retranslation to improve comprehensibility across cultures and languages. Overall, the validity, reliability, and measurement equivalence between the English and Chinese versions complement and support the use of the FACT-Cog as a tool for future clinical research.
